Last July, Sen. Claire McCaskill (D-Mo.) asked several drug makers and wholesalers to provide various forms of information about the steps they have taken to mitigate the opioid epidemic. But one company, Teva Pharmaceuticals (TEVA), is “stonewalling,” as far as she is concerned.

Instead of turning over documents about monitoring suspicious orders — a key focus of her investigation — Teva responded with two brief letters describing those efforts. And in a second letter sent in October, Teva attorneys maintained the drug maker has been willing to discuss, “at a general level,” the information requested, but acknowledged the company “declined to produce the documents.”

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • They have been waffling and withholding information for 20 years. No one one wants to look at the obscene profits, the last 20 years of weaponized drug marketing or the industries that are still profiting from misinformation, death and despair. No one wants to look at the Facts. They used this Epidemic of Despair, to hide the death Rates. They are currently using it to obscure the number of adverse events, failed surgeries and injured workers. It was a cost benefit analysis, meant to help all of the health related industries increase their profitability. At the same time they chose to ignore every other social problem. Pharma and their media and industry friends are still misleading the public. Since 2000 they have found that bought off politicians, cherry picked numbers, lies and industry insiders can easily distract people from the Facts. Their lawyers will probably argue that all of that information is proprietary anyway.

  • A question for our scribe – how much, if any, of TEVA’s opioid business arrived with the purchase of Allergan’s (nee Watson etc) generics business? One might wonder if that is the case, whether they even really know the answer / have the numbers?
    Could this be another case of the curse of a legacy business? This Observer (“079”) knoweth not and defers to the sage of Pharmalot.

Comments are closed.

Sign up to receive a free weekly opinions recap from our community of experts.
Privacy Policy